Flick the barrel to move bubbles to the top
CT-996 would directly compete with oral products such as Rybelsus approved for patients with T2D and other oral pipeline developmental products from companies like Amgen, D&D Pharmatech, Eli Lilly, Hengrui, Pfizer, Sciwind Biosciences, Structure, and Viking
Bosch E, Espins JJ, Fabregues F, et al
Mir Ali, MD, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, not involved in this research, explained what this means for people taking GLP-agonists
No hidden membership fee
Online forums and local meetups can serve as platforms for exchanging tips on managing symptoms, discussing treatment options, and sharing personal stories